Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma

被引:117
作者
Fitzpatrick, Anne M. [1 ]
Holguin, Fernando [2 ]
Teague, W. Gerald [1 ]
Brown, Lou Ann S. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
关键词
asthma; children; innate immunity; alveolar macrophage; respiratory infection;
D O I
10.1016/j.jaci.2008.03.008
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Lower respiratory tract infection is a differentiating feature of children with poorly controlled asthma. Objective: Given the role of alveolar macrophages (AMs) in innate immunity, we hypothesized that AM phagocytosis might be impaired in poorly controlled asthma. Methods: Bronchoalveolar lavage fluid AMs were isolated from 28 asthmatic children (moderate asthma, n = 12; severe asthma, n = 16), 10 nonasthmatic children with chronic cough treated with inhaled corticosteroids, and 10 healthy adult control subjects. AMs were stimulated with LPS and exposed to fluorescein isothiocyanate-conjugated Staphylococcus aureus for 2 hours. Phagocytosis was quantified by using a phagocytic index (PI) calculated from the percentage of phagocytic cells multiplied by the relative fluorescence (RFU) units of S aureus per cell. Apoptosis was determined from the percentage of cells positive for poly (adenosine diphosphate-ribose) polymerase. Results: Phagocytosis as measured by using the unstimulated PI was decreased in subjects with poorly controlled asthma (healthy control subjects, 9330 3992 RFU; chronic cough, 9042 +/- 5976 RFU; moderate asthma, 4361 +/- 2536 RFU; severe asthma, 3153 +/- 1886 RFU; P<.001) and remained unchanged with LPS stimulation. Children with severe asthma also had increased AM apoptosis, both the unstimulated and LPS-simulated states (P<.001), which correlated with the PI. Conclusions: AM function is compromised in children with poorly controlled asthma and is characterized by decreased phagocytosis and increased apoptosis.
引用
收藏
页码:1372 / 1378
页数:7
相关论文
共 36 条
[1]  
ALDEREN A, 1999, ANNU REV IMMUNOL, V17, P593
[2]   Effect of inhaled endotoxin on airway and circulating inflammatory cell phagocytosis and CD11b expression in atopic asthmatic subjects [J].
Alexis, NE ;
Eldridge, MW ;
Peden, DB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (02) :353-361
[3]  
Alexis NE, 2001, AM J PHYSIOL-LUNG C, V280, pL369
[4]   ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 [J].
American Thoracic Society ;
European Respiratory Society .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) :912-930
[6]   LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[7]   Endocytic internalization of adenovirus, nonspecific phagocytosis, and cytoskeletal organization are coordinately regulated in alveolar macrophages by GM-CSF and PU.1 [J].
Berclaz, PY ;
Zsengellér, Z ;
Shibata, Y ;
Otake, K ;
Strasbaugh, S ;
Whitsett, JA ;
Trapnell, BC .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6332-6342
[8]   GM-CSF, via PU.1, regulates alveolar macrophage FcγR-mediated phagocytosis and the IL-18/1FN-γ-mediated molecular connection between innate and adaptive immunity in the lung [J].
Berclaz, PY ;
Shibata, Y ;
Whitsett, JA ;
Trapnell, BC .
BLOOD, 2002, 100 (12) :4193-4200
[9]   Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease [J].
Berenson, Charles S. ;
Garlipp, Mary Alice ;
Grove, Lori J. ;
Maloney, Jane ;
Sethi, Sanjay .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (10) :1375-1384
[10]   ENHANCED SUPEROXIDE PRODUCTION BY ALVEOLAR MACROPHAGES AND AIR-SPACE CELLS, AIRWAY INFLAMMATION, AND ALVEOLAR MACROPHAGE DENSITY CHANGES AFTER SEGMENTAL ANTIGEN BRONCHOPROVOCATION IN ALLERGIC SUBJECTS [J].
CALHOUN, WJ ;
REED, HE ;
MOEST, DR ;
STEVENS, CA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (02) :317-325